13F History

WYNNEFIELD CAPITAL INC

Holdings History for LIFECORE BIOMEDICAL, INC. DE - COM (LFCR)

Symbol: LFCR on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	10.9%		$24.3M	4.92M			$4.93	Q3 2024
6/30/2024	11.3%	-0.01%	$25.2M	4.92M	-4,566	-0.09%	$5.13	Q2 2024
3/31/2024	10.4%		$26.1M	4.92M			$5.31	Q1 2024
12/31/2023	11.8%		$30.5M	4.92M			$6.19	Q4 2023
9/30/2023	17%		$37.1M	4.92M			$7.54	Q3 2023
6/30/2023	23.8%		$47.6M	4.92M			$9.67	Q2 2023
3/31/2023	12%	+1.13%	$18.6M	4.92M	+461,035	+10.3%	$3.77	Q1 2023
12/31/2022	16.7%	+3.47%	$28.9M	4.46M	+929,223	+26.3%	$6.48	Q4 2022
9/30/2022	16.6%		$31.4M	3.53M			$8.89	Q3 2022
6/30/2022	17.8%		$35.2M	3.53M			$9.97	Q2 2022
3/31/2022	15.6%	+1.71%	$40.9M	3.53M	+387,400	+12.3%	$11.58	Q1 2022
12/31/2021	12.5%		$34.9M	3.15M			$11.10	Q4 2021
9/30/2021	15.7%		$29M	3.15M			$9.22	Q3 2021
6/30/2021	16.3%	+1.25%	$35.4M	3.15M	+240,587	+8.28%	$11.25	Q2 2021
3/31/2021	15.3%	+0.11%	$30.7M	2.91M	+20,000	+0.69%	$10.55	Q1 2021
12/31/2020	15.8%	+0.05%	$31.3M	2.89M	+10,000	+0.35%	$10.85	Q4 2020
9/30/2020	17.4%		$27.9M	2.88M			$9.72	Q3 2020
6/30/2020	16.9%	+0.03%	$22.9M	2.88M	+5,000	+0.17%	$7.96	Q2 2020
3/31/2020	23.7%		$24.9M	2.87M			$8.69	Q1 2020
12/31/2019	21.7%		$32.5M	2.87M			$11.31	Q4 2019
9/30/2019	16.6%	+0.43%	$31.2M	2.87M	+75,000	+2.68%	$10.87	Q3 2019
6/30/2019	13.4%	+0.29%	$26.2M	2.8M	+60,000	+2.19%	$9.37	Q2 2019
3/31/2019	16%	+0.31%	$33.6M	2.74M	+52,900	+1.97%	$12.28	Q1 2019
12/31/2018	16.1%		$31.8M	2.68M			$11.84	Q4 2018
9/30/2018	16.1%		$38.6M	2.68M			$14.40	Q3 2018
6/30/2018	14.8%		$40M	2.68M			$14.90	Q2 2018
3/31/2018	12.2%		$35M	2.68M			$13.05	Q1 2018
12/31/2017	11.7%		$33.8M	2.68M			$12.60	Q4 2017
9/30/2017	12.4%		$34.7M	2.68M			$12.95	Q3 2017
6/30/2017	13.3%		$39.8M	2.68M			$14.85	Q2 2017
3/31/2017	11.8%		$32.2M	2.68M			$12.00	Q1 2017
12/31/2016	13.3%		$37M	2.68M			$13.80	Q4 2016
9/30/2016	12%		$36M	2.68M			$13.41	Q3 2016
6/30/2016	10.4%		$28.9M	2.68M			$10.76	Q2 2016
3/31/2016	11.1%		$28.2M	2.68M			$10.50	Q1 2016
12/31/2015	10.7%	+0.07%	$31.7M	2.68M	+17,400	+0.65%	$11.83	Q4 2015
9/30/2015	12.5%	+0.07%	$31.1M	2.67M	+15,000	+0.57%	$11.67	Q3 2015
6/30/2015	14.7%		$38.2M	2.65M			$14.43	Q2 2015
3/31/2015	16.3%		$37M	2.65M			$13.95	Q1 2015
12/31/2014	15.4%	+0.12%	$36.6M	2.65M	+20,000	+0.76%	$13.81	Q4 2014
9/30/2014	14%	+4.86%	$30M	2.63M	+915,600	+53.4%	$11.42	Q3 2014
6/30/2014	9.86%		$21.4M	1.71M			$12.49	Q2 2014
3/31/2014	9.34%	+0.42%	$19.1M	1.71M	+76,414	+4.67%	$11.16	Q1 2014
12/31/2013	8.57%		$19.1M	1.64M			$11.69	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.